First-Ever Meta-Analysis of Exoskeleton Technologies

ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), the leading global exoskeleton developer and manufacturer, announced today the publication of the first systematic review and industry-wide meta-analysis of existing published literature assessing the clinical effectiveness and safety of powered exoskeleton-assisted walking in patients with spinal cord injury (“SCI”). The report summarizing the research concluded that “powered exoskeletons Read more about First-Ever Meta-Analysis of Exoskeleton Technologies[…]